Analysis of biopharmaceuticals with gel electrophoresis

HWI pharma services GmbH offers a wide range of services in the field of biopharmaceutical analysis for human therapeutic applications.  Gel electrophoresis, which is highly versatile in pharmaceutical quality control and is used for the examination of peptides, proteins, and nucleic acids.

The Agilent 2100 Bioanalyzer system and various DNA kits enable automated size determination and quantification of products generated through RT-PCR, gene expression, cloning, or restriction digestion. For instance, the High Sensitivity DNA kit allows the analysis of DNA fragments ranging from 50 to7000 bp with comparable sensitivity in the lower pg/μL range. Corresponding chips are also available for the examination of ribonucleic acids, which allow the assessment of typical quality control parameters such as RNA integrity, quality, and content. By choosing microchip-based gel electrophoresis for the quality control of your biopharmaceuticals, you benefit from faster analysis times, precise results, and cost savings.

More information you can find here: Präsentation Technology Platform Biomolecules